Home / Events / NF Clinical Symposium

NF clinical symposium

Bridging research and Clinical Impact

A day to stimulate collaborations, showcase progress and fuel new ideas to conquer NF.

The NF Clinical Symposium is an opportunity for health professionals and researchers to come together, in person and virtually, to network and discuss the latest in medical management, treatment and research into neurofibromatosis in Australia and around the globe.

2025 conference summary

110 researchers and health professionals with a strong interest in NF gathered in August 2025 for a diverse program diving into the complexities of NF and ongoing research into the condition. 

Over 20 presentations were given, ranging from developments in gene therapy and stem cell research to trials of whole-body MRI screening and studies into future innovative solutions in patient care, management and treatment.

Much progress is happening nationally and internationally in this space and we are grateful to our colleagues in the health space for their dedication and excellence.

MEET NF Researchers in Australia

A series of interviews with speakers from the NF Clinical Symposium 2025
Dr Natalie Pride

Dr Pride leads the neuropsychology research program at the Kids Neuroscience Centre at The Children’s Hospital at Westmead in Sydney. 

Dr Hayley Darke

Dr Darke is a research neuropsychologist at the Murdoch Children’s Research Institute (MCRI) and works as a clinical neuropsychologist at the Neurofibromatosis Clinic at the Royal Children’s Hospital in Melbourne.

Dr Kiymet Bozaoglu

Dr Bozaglu is a molecular biologist and Team Leader in the Neurogenetics Laboratory at the Murdoch Children’s Research Institute in Melbourne, affiliated with the Department of Paediatrics and the University of Melbourne. 

Kylie Clark

Kylie coordinates the multidisciplinary NF Clinic at The Royal Children’s Hospital (RCH) in Melbourne.

Dr Brooke Gardiner

Dr Gardiner is a Clinical Genetics and Genetics Research Fellow at the Royal North Shore Hospital (RNSH) in Sydney. 

Key findings for patients and carers

Learn about the latest developments without the medical jargon, from a selection of presentations.

Understanding sleep in children with NF1


The information provided below is a summary of the presentation titled 'Sleep Problems and Circadian Rhythm Disruption in Children with Neurofibromatosis Type 1: Evidence from Actigraphy and Nocturnal Melatonin' given by Dr Natalie Pride on 4th August 2025 at the NF Clinical Symposium in Sydney.

Remote listening device offers a boost to speech perception in NF1


The information provided below is a summary of the presentation titled Supporting Auditory Processing Difficulties in Children with NF1 Using an Assistive Listening Device given by Dr Hayley Darke on 4th August 2025 at the NF Clinical Symposium in Sydney.

Exploring NF1-patient specific processes of brain development using their own unique stem cells

The information provided below is a summary of the presentation titled 'Modelling the neurodevelopmental phenotype of NF1 using patient-derived stem cells' given by Dr Kiymet Bozaoglu on 4th August 2025 at the NF Clinical Symposium in Sydney.

Neurofibromatosis in early adulthood: A brief guide

The information provided below is a summary of the presentation titled 'Neurofibromatosis in early adulthood-A brief guide' given by Kylie Clark on 4th August 2025 at the NF Clinical Symposium in Sydney.


Challenges faced by patients with NF when planning to have children

The information below is a summary of the presentation titled ‘NFSURE Study: Supporting Reproductive Choices and Decision-making for Adults with Neurofibromatosis’ given by Dr Brooke Gardiner on 4th August 2025 at the NF Clinical Symposium in Sydney.

Key findings for Health Care Professionals

Dive in to the latest insights and updates with all the important details, from a selection of presentations.

Sleep Matters in Children with NF1



A summary of the presentation titled 'Sleep Problems and Circadian Rhythm Disruption in Children with Neurofibromatosis Type 1: Evidence from Actigraphy and Nocturnal Melatonin' given by Dr Natalie Pride on 4th August 2025 at the NF Clinical Symposium in Sydney.

Remote listening device offers a boost to speech perception in NF1


A summary of the presentation titled 'Supporting Auditory Processing Difficulties in Children with NF1 Using an Assistive Listening Device' given by Dr Hayley Darke on 4th August 2025 at the NF Clinical Symposium in Sydney.

Exploring NF1-patient specific processes of brain development using their own unique stem cells

A summary of the presentation titled 'Modelling the neurodevelopmental phenotype of NF1 using patient-derived stem cells' given by Dr Kiymet Bozaoglu on 4th August 2025 at the NF Clinical Symposium in Sydney.

Neurofibromatosis in early adulthood: A brief guide

A summary of the presentation titled 'Neurofibromatosis in early adulthood-A brief guide' given by Kylie Clark on 4th August 2025 at the NF Clinical Symposium in Sydney.


Challenges faced by patients with NF when planning to have children

A summary of the presentation titled ‘NFSURE Study: Supporting Reproductive Choices and Decision-making for Adults with Neurofibromatosis’ given by Dr Brooke Gardiner on 4th August 2025 at the NF Clinical Symposium in Sydney.

the 2025 symposium was Sponsored By